Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
55 GBX | +5.77% | +4.76% | -11.29% |
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 59 | 01/20/01 | |
Mark Hahn
DFI | Director of Finance/CFO | 61 | 01/20/01 |
Kavita Aggarwal
CTO | Chief Tech/Sci/R&D Officer | - | 01/23/01 |
Tara Rheault
CTO | Chief Tech/Sci/R&D Officer | 49 | 01/19/01 |
Kathleen Rickard
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/19/01 |
Victoria Stewart
IRC | Investor Relations Contact | - | 01/19/01 |
Corporate Officer/Principal | - | 01/20/01 | |
Ostra Jewell
HRO | Human Resources Officer | - | 01/22/01 |
Caroline Diaz
LAW | General Counsel | - | 01/21/01 |
Matthew Casbon
SAM | Sales & Marketing | - | 24/22/24 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Mahendra Shah
BRD | Director/Board Member | 79 | 17/16/17 |
Vikas Sinha
BRD | Director/Board Member | 60 | 12/16/12 |
David Ebsworth
CHM | Chairman | 69 | 01/14/01 |
Director/Board Member | 71 | 10/15/10 | |
Martin Edwards
BRD | Director/Board Member | 68 | 01/19/01 |
Sven Ullman
BRD | Director/Board Member | 68 | 10/15/10 |
Chief Executive Officer | 59 | 01/20/01 | |
Director/Board Member | 59 | 01/23/01 | |
Lisa Deschamps
BRD | Director/Board Member | 52 | 01/21/01 |
James Brady
BRD | Director/Board Member | 61 | 14/22/14 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 608,138,246 | 458,671,402 ( 75.42 %) | 0 | 75.42 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VRNA Stock
- VRP Stock
- Company Verona Pharma plc